In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|4|477-487

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.4, 2015-04, pp. : 477-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single‐center clinical analysis

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 359-362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subsequent treatment of epidermal growth factor receptor‐tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 678-686

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 99-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

The chemokine receptor CX3CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury

By  

EMBO Molecular Medicine, Vol. 10, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of p53‐targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 1060-1069

John Wiley & Sons Inc

Access to resources Recommend Favorite